Literature DB >> 6129134

Dissociation of steroid binding to receptors and steroid induction of biological activity in a glucocorticoid-responsive cell.

L Mercier, E B Thompson, S S Simons.   

Abstract

Glucocorticoid responses in two independently derived lines of rat hepatoma tissue culture cells (HTC and FU5-5) were examined. FU5-5 cells exhibited induction of the enzyme tyrosine aminotransferase (TAT) at concentrations of dexamethasone that were approximately 7-fold lower than that required for HTC cells. FU5-5 cells also displayed substantial TAT induction with steroids that were partial agonists, or antagonists, in HTC cells. The increased sensitivity of FU5-5 cells was not, however, due to an increased affinity of FU5-5 cell receptors for dexamethasone, as determined from cell-free and whole cell binding experiments. The differential steroid sensitivity for TAT induction was observed with three other, structurally different glucocorticoids, thus apparently ruling out steroid metabolism in one of the cell lines as a cause. Also, induction of TAT in FU5-5 cells occurred at approximately 9-fold lower steroid concentrations than were required for the induction of glutamine synthetase (GS) in the same cells. Thus, the dose-response curves for TAT induction in HTC cells and for GS induction in FU5-5 cells are closely correlated with the saturation curve for whole cell steroid binding to receptor sites, while the dose-response curve for TAT induction in FU5-5 cells is shifted to lower steroid concentrations. This represents the first report of dissociation of two supposedly primary, glucocorticoid-induced functions and indicates that identical receptor-mediated processes cannot be utilized by FU5-5 cells for the induction of TAT and GS. The involvement of second messengers or different nuclear processes are possible explanations for the unusual behavior of FU5-5 cells during glucocorticoid induction of TAT.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129134     DOI: 10.1210/endo-112-2-601

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes.

Authors:  Timothy E Reddy; Jason Gertz; Gregory E Crawford; Michael J Garabedian; Richard M Myers
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

2.  Genomic organization of human GMEB-1 and rat GMEB-2: structural conservation of two multifunctional proteins.

Authors:  H Zeng; S Kaul; S S Simons
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

Review 3.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 4.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

5.  Modulation of transcription parameters in glucocorticoid receptor-mediated repression.

Authors:  Yunguang Sun; Yong-Guang Tao; Benjamin L Kagan; Yuangzheng He; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2008-05-21       Impact factor: 4.102

6.  Steroid inhibition of calcitriol-induced prolactin production in GH4C1 cells. Specificity and sensitivity.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 7.  What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.

Authors:  S Stoney Simons
Journal:  Bioessays       Date:  2008-08       Impact factor: 4.345

8.  Glucocorticoid receptor-dependent inhibition of cellular proliferation in dexamethasone-resistant and hypersensitive rat hepatoma cell variants.

Authors:  P W Cook; K T Swanson; C P Edwards; G L Firestone
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.